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Stroke patients have higher mortality than  sex- matched and  age- matched subjects who have not experienced a 
stroke.1 During the past few decades, death rates from stroke 
have declined.2,3 Some of the improvement in stroke mortal-
ity might be associated with improvement in acute care and 
 long- term preventive treatment based on better evaluation 
of stroke etiologies, introduction of new medications, and 
aggressive control of risk factors.4
The ischemic stroke subtype is an important determinant of 
mortality in many prospective  community- based studies and 
clinical trials.5–9 Although determining the stroke mechanism 
is important for better treatment, the etiology of stroke remains 
undetermined in many patients,10–12 because multiple etiologies 
are identified, physicians fail to identify the etiology despite 
extensive  work- up, or evaluations are incomplete. Whereas 
stroke of undetermined etiology is common,  long- term mor-
tality in this group of patients remains unknown because 
most studies excluded patients with stroke of undetermined 
etiology because of the unclear nature.8 Moreover, mortality 
in patients with stroke of undetermined etiology might dif-
fer according to the reasons for the undetermined etiology. In 
this study, we aimed to determine the  long- term mortality of 
patients with stroke of undetermined etiology and to investi-
gate the impact of stroke evaluation on  long- term mortality in 
patients with acute ischemic stroke.
Subjects and Methods
Patients and Evaluation
Subjects for this study were drawn from consecutive patients with 
acute ischemic stroke who had been registered in the Yonsei Stroke 
Registry over a 10-year period (July 1997–June 2007). The Yonsei 
University Severance Hospital is a 2000-bed general hospital lo-
cated in the western part of Seoul, the capital city of South Korea. 
Approximately 80% of stroke patients who are admitted to the study 
hospital are from Seoul and  Gyeong- gi province, with ≈20 million 
inhabitants (Supplemental Figure I). The study hospital is 1 of many 
large hospitals in that area where patients can visit. The Yonsei 
Stroke Registry is a prospective  hospital- based registry for patients 
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with cerebral infarction or transient ischemic attack within 7 days 
after symptom onset.10 During admission, all patients were thoroughly 
investigated for medical history, clinical manifestations, and presence 
of vascular risk factors. All registered patients underwent brain imag-
ing studies including brain computed tomography (CT) or magnetic 
resonance imaging. An angiographic study using CT angiography, 
magnetic resonance angiography, or digital subtraction angiography 
was the standard evaluation tool. Every patient was evaluated with 
12-lead electrocardiography (ECG), chest  x- ray, lipid profile, and 
standard blood tests. For patients younger than 45 years old, addi-
tional blood tests for coagulopathy or prothrombotic conditions were 
performed.13 Transesophageal echocardiography was a part of the 
standard evaluation, except in patients with decreased consciousness, 
impending brain herniation, poor systemic conditions, inability to 
accept an esophageal transducer because of swallowing difficulty or 
tracheal intubation, or lack of informed consent. Transthoracic echo-
cardiography, heart CT, and Holter monitoring were performed in the 
selected patients.13–15 A stroke unit was opened in the study hospital 
on December 2002. Since then, most patients have been admitted to 
the stroke unit and are monitored continuously with ECG during their 
stay in the stroke unit. Since July 2006, heart CT using multislice CT 
had been performed for the evaluation of the coronary artery, aorta, 
and heart. Patients were indicated for heart CT when they had at least 
one of the following: (1) presence of atherosclerosis in the intracra-
nial or extracranial cerebral artery; (2) presence of ≥2 risk factors 
for coronary artery disease such as hypertension, diabetes mellitus, 
dyslipidemia, cigarette smoking, and central obesity; and (3) old age 
(males older than 45 years, females older than 55 years).16
Among the consecutive patients who had been registered in the 
prospective stroke registry, those with transient ischemic attack were 
excluded. When a patient was admitted more than twice because of 
recurrent strokes, only data for the first admission were used for this 
study. Initial stroke severity was determined by National Institute of 
Health Stroke Scale scores and score tertiles were used for the analy-
sis. This study was approved by the Severance Hospital Institutional 
Review Board of Yonsei University Health System.
Stroke Subtype Classification and  
Clinical Variables
The stroke subtype was determined according to the Trial of ORG 
10172 in Acute Stroke Treatment (TOAST) classification.17 Briefly, 
large artery atherosclerosis is defined when there is significant 
(≥50%) stenosis of the large artery relevant to the acute infarction. 
Cardioembolism is defined when there is at least 1 potential cardiac 
source of embolism, which is defined in the TOAST classification. 
A patient with a lacunar infarction should have 1 of the classic clini-
cal lacunar syndrome and a relevant subcortical hemispheric or brain 
stem lesion with a diameter <1.5 cm. Stroke of other determined 
etiology includes patients with a rare cause of stroke, such as non-
atherosclerotic vasculopathy, hypercoagulable state, and hematologic 
disorder. Stroke of undetermined etiology is defined when the mecha-
nism of stroke cannot be determined and is further subdivided into 
undetermined etiology because of multiple causes identified, unde-
termined etiology attributable to negative evaluation despite exten-
sive  work- up, and undetermined etiology attributable to incomplete 
evaluation.17 An incomplete evaluation was defined when the essen-
tial studies such as brain imaging (CT/magnetic resonance imaging 
for diagnosis and determining the stroke pattern), angiographic eval-
uation (CT angiography, magnetic resonance angiography, or digi-
tal subtraction angiography for determination of atherosclerosis or 
arteriopathy), or ECG (for detection of cardiac sources of embolism) 
were not performed. Echocardiographic studies were not considered 
as essential studies. The patients who lacked of any those essential 
studies were classified as those with undetermined etiology because 
of incomplete evaluation, except patients who did not undergo an-
giographic evaluation but had  high- risk potential cardiac sources 
of embolism. They were classified as cardioembolism according to 
the original TOAST classification.17 Therefore, typical patients with 
an incomplete evaluation were those who did not undergo evalua-
tion for cerebral arteries and had not high risk for cardiac sources of 
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with cerebral infarction or transient ischemic attack within 7 days 
after symptom onset.10 During admission, all patients were thoroughly 
investigated for medical history, clinical manifestations, and presence 
of vascular risk factors. All registered patients underwent brain imag-
ing studies including brain computed tomography (CT) or magnetic 
resonance imaging. An angiographic study using CT angiography, 
magnetic resonance angiography, or digital subtraction angiography 
was the standard evaluation tool. Every patient was evaluated with 
12-lead electrocardiography (ECG), chest  x- ray, lipid profile, and 
standard blood tests. For patients younger than 45 years old, addi-
tional blood tests for coagulopathy or prothrombotic conditions were 
performed.13 Transesophageal echocardiography was a part of the 
standard evaluation, except in patients with decreased consciousness, 
impending brain herniation, poor systemic conditions, inability to 
accept an esophageal transducer because of swallowing difficulty or 
tracheal intubation, or lack of informed consent. Transthoracic echo-
cardiography, heart CT, and Holter monitoring were performed in the 
selected patients.13–15 A stroke unit was opened in the study hospital 
on December 2002. Since then, most patients have been admitted to 
the stroke unit and are monitored continuously with ECG during their 
stay in the stroke unit. Since July 2006, heart CT using multislice CT 
had been performed for the evaluation of the coronary artery, aorta, 
and heart. Patients were indicated for heart CT when they had at least 
one of the following: (1) presence of atherosclerosis in the intracra-
nial or extracranial cerebral artery; (2) presence of ≥2 risk factors 
for coronary artery disease such as hypertension, diabetes mellitus, 
dyslipidemia, cigarette smoking, and central obesity; and (3) old age 
(males older than 45 years, females older than 55 years).16
Among the consecutive patients who had been registered in the 
prospective stroke registry, those with transient ischemic attack were 
excluded. When a patient was admitted more than twice because of 
recurrent strokes, only data for the first admission were used for this 
study. Initial stroke severity was determined by National Institute of 
Health Stroke Scale scores and score tertiles were used for the analy-
sis. This study was approved by the Severance Hospital Institutional 
Review Board of Yonsei University Health System.
Stroke Subtype Classification and  
Clinical Variables
The stroke subtype was determined according to the Trial of ORG 
10172 in Acute Stroke Treatment (TOAST) classification.17 Briefly, 
large artery atherosclerosis is defined when there is significant 
(≥50%) stenosis of the large artery relevant to the acute infarction. 
Cardioembolism is defined when there is at least 1 potential cardiac 
source of embolism, which is defined in the TOAST classification. 
A patient with a lacunar infarction should have 1 of the classic clini-
cal lacunar syndrome and a relevant subcortical hemispheric or brain 
stem lesion with a diameter <1.5 cm. Stroke of other determined 
etiology includes patients with a rare cause of stroke, such as non-
atherosclerotic vasculopathy, hypercoagulable state, and hematologic 
disorder. Stroke of undetermined etiology is defined when the mecha-
nism of stroke cannot be determined and is further subdivided into 
undetermined etiology because of multiple causes identified, unde-
termined etiology attributable to negative evaluation despite exten-
sive  work- up, and undetermined etiology attributable to incomplete 
evaluation.17 An incomplete evaluation was defined when the essen-
tial studies such as brain imaging (CT/magnetic resonance imaging 
for diagnosis and determining the stroke pattern), angiographic eval-
uation (CT angiography, magnetic resonance angiography, or digi-
tal subtraction angiography for determination of atherosclerosis or 
arteriopathy), or ECG (for detection of cardiac sources of embolism) 
were not performed. Echocardiographic studies were not considered 
as essential studies. The patients who lacked of any those essential 
studies were classified as those with undetermined etiology because 
of incomplete evaluation, except patients who did not undergo an-
giographic evaluation but had  high- risk potential cardiac sources 
of embolism. They were classified as cardioembolism according to 
the original TOAST classification.17 Therefore, typical patients with 
an incomplete evaluation were those who did not undergo evalua-
tion for cerebral arteries and had not high risk for cardiac sources of 
embolism. Stroke classification was determined at weekly stroke con-
ferences on the basis of a consensus among stroke specialists, and 
was prospectively entered into the computerized database.10
Risk Factors
Hypertension was defined when a patient had a resting systolic blood 
pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg on 
repeated measurements during hospitalization or had been using an-
tihypertensive medication. Diabetes mellitus was diagnosed when a 
patient had a fasting plasma glucose value ≥7 mmol/L or had been 
treated with an oral hypoglycemic agent or insulin. Hyperlipidemia 
was diagnosed when a patient had a fasting serum total cholesterol 
level ≥6.2 mmol/L,  low- density lipoprotein cholesterol ≥4.1 mmol/L, 
or if the patient had been using a  lipid- lowering drug after the diagno-
sis of hyperlipidemia. A current smoker was defined as an individual 
who smoked at the time of stroke or had quit smoking within 1 year.
 Short- Term Functional Outcome and  
Long- Term Mortality
 Short- term functional outcomes at 3 months were determined with 
the modified Rankin Scale. Poor outcome was defined as an modified 
Rankin Scale score >2.  Long- term mortality and causes of death were 
identified using death certificates from the Korean National Statistical 
Office. In Korea, by law, all deaths of Koreans must be reported to 
the National Statistical Office. Deaths during the hospitalization or 
within 48 hours after discharge from a hospital are certified by the 
physician who examined the decedent. For deaths not certified by 
physicians, any vague or missing item on the death certificate is clari-
fied by the National Statistical Office via telephone.18 The causes 
of death in death statistics of the Korean National Statistical Office 
have been reported to be reliable.3,19 Deaths among subjects from July 
1997 to December 31, 2007, were confirmed by matching the infor-
mation in the death records and identification numbers assigned to 
subjects at birth.20 The cause of death was coded according to the 
International Classification of Disease, 10th revision. Cardiovascular 
death included fatal stroke (I60–64) and fatal ischemic heart disease 
caused by myocardial infarction (I21–23, I46).
Standardized Mortality Ratio
We used indirect standardization method and calculated standard-
ized mortality ratio (SMR) to compare the mortality in patients with 
stroke and the mortality in the general Korean population. The SMR 
is the ratio of observed number of deaths in the study population to 
expected number of deaths estimated from the standard population.21 
For the calculation of SMR, we used  sex- specific and  age- specific 
mortality data from the entire Korean population in 2003, which was 
the median year of the study. The SMR >1.0 means that excess deaths 
occurred in the patient population compared with the general popu-
lation of same sex and age.  Sex- adjusted and  age- adjusted SMR 
with 95% confidence interval (CI) was calculated for overall stroke 
patients as well as for patients with each stroke subtype. To calcu-
late 95% CI of SMR, the  mid- P test with Miettinen modification was 
used.22 The SMR per 100000  person- years was also calculated.
Statistical Analysis
SPSS for Windows (version 18.0; SPSS, Chicago, IL) and R package 
version 2.15.0 (http://www.R-project.org) were used for statistical 
analysis. The Pearson χ2 test was used to compare frequencies. For 
continuous variables, data distributions were examined for normality 
using the  Kolmogorov- Smirnov test. Provided that the data did not 
deviate from a normal distribution, the mean and standard deviation 
were calculated and independent sample t tests were used for com-
parisons. For data that were not normally distributed, we reported 
descriptive statistics as the median and interquartile range (IQR) and 
compared them using the  Mann–Whitney U test. Independent predic-
tors for poor outcome at 3 months were determined using the logis-
tic regression analysis. Variables with P<0.1 in univariate analysis 
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were entered into the multivariate model. To compare the  long- term 
mortality according to the TOAST classification, a  Kaplan–Meier 
analysis was used to estimate survival conditions and the  log- rank 
test was used to compare rate estimates. Cumulative death rates 
within 30 days, 1 year, and 3 years were also calculated. The Cox 
proportional hazard regression analysis was performed to calculate 
crude and adjusted hazard ratios with 95% CI. For univariate Cox 
analysis, the TOAST classification and possible confounding factors 
including age, sex, hypertension, diabetes, current smoking, hyperlip-
idemia, and initial National Institutes of Health Stroke Scale scores 
were compared. Variables with P<0.1 in the univariate analyses were 
entered into the multivariate Cox regression model to identify inde-
pendent predictors of  long- term mortality. Atrial fibrillation was not 
entered into the multivariate model because atrial fibrillation was 
exclusively found in patients with cardioembolism or undetermined 
etiology because of multiple causes. Internal validation of the models 
was performed by bootstrapping (2000 resampling) and estimation of 
the concordance index.23
Results
Study Patients
During the study period, 3965 patients were admitted and 
registered in the stroke registry. After excluding patients with 
transient ischemic attack (n=258), recurrent stroke after the 
index event (n=196), or missing data (n=233), 3278 patients 
with their  first- ever stroke were enrolled in this study and 
were  followed- up for a median of 3.4 years (IQR, 1.5–5.7). 
The median age of the patients was 65 years (IQR, 57–72) 
and 61.7% of the patients were male. Overall, 49.3% were 
younger than 65 years and 2.6% were older than 85 years. 
Female patients were older than male patients (67 years and 
IQR, 60–74.75 vs 63 years and IQR, 55–71; P<0.001). The 
initial median National Institutes of Health Stroke Scale score 
was 4 (IQR, 1.25–8). The most frequent stroke subtype was 
undetermined etiology (37%), followed by large artery athero-
sclerosis (24.7%), cardioembolism (20.8%), lacunar infarc-
tion (14.9%), and stroke of other determined etiology (2.9%). 
Among the undetermined etiologies, negative evaluation was 
most frequent (21.2%), followed by multiple causes (10.6%) 
and incomplete evaluation (4.8%).
Demographic characteristics according to the stroke sub-
type are shown in Table 1. When comparing patients with 
other stroke subtypes, those with an incomplete evaluation 
Table 1. Demographic Characteristics According to the Stroke Subtypes
Total  
3278 (100)
LAA  
811 (24.7)
CE  
682 (20.8)
LAC  
489 (14.9)
SOD  
94 (2.9)
UM  
349 (10.6)
UN  
696 (21.2)
UI  
157 (4.8) P *
Age, y
Mean±SD 63.7±12.1 65.4±10.5 64.6±12.9 62.5±10.6 46.6±16.2 65.6±11.1 62.6±12.0 65.9±12.1
Median 65 (57–72) 66 (59–73) 66 (57–74) 63 (56–70) 46.5 (34.75–58.5) 66 (59–73.5) 64 (55–71) 66 (58–74.5) 0.040
<60 1054 (32.2) 209 (25.8) 204 (29.9) 171 (35.0) 71 (75.5) 100 (28.7) 256 (36.8) 43 (27.4)
60–79 1961 (59.8) 541 (66.7) 397 (58.2) 291 (59.5) 22 (23.4) 216 (61.9) 399 (57.3) 95 (60.5)
≥80 263 (8.0) 61 (7.5) 81 (11.9) 27 (5.5) 1 (1.1) 33 (9.5) 41 (5.9) 19 (12.1)
Male 2022 (61.7) 528 (65.1) 376 (55.1) 294 (60.1) 56 (59.6) 239 (68.5) 441 (63.4) 88 (56.1) 0.137
Hypertension 2304 (70.3) 603 (74.4) 422 (61.9) 359 (73.4) 35 (37.2) 274 (78.5) 509 (73.1) 102 (65.0) 0.135
Diabetes 1011 (30.8) 309 (38.1) 142 (20.8) 156 (31.9) 11 (11.7) 114 (32.7) 216 (31.0) 63 (40.1) 0.010
Atrial fibrillation 534 (16.3) 0 (0) 422 (61.9) 0 (0) 0 (0) 112 (32.1) 0 (0) 0 (0) <0.001
Smoking 1282 (39.1) 356 (43.9) 225 (33) 196 (40.1) 36 (38.3) 135 (38.7) 299 (43.0) 35 (22.3) <0.001
Hyperlipidemia 377 (11.6) 119 (14.7) 65 (9.6) 56 (11.5) 9 (9.8) 46 (13.2) 68 (9.8) 14 (9) 0.314
Initial NIHSS 
scores
4 (1.25–8) 4 (2–9) 7 (2–15) 3 (1–4) 3 (1–7.5) 3 (1–7) 3 (1–6) 6 (3–17) <0.001
<2 745 (25.0) 163 (21.6) 122 (19.6) 117 (27.5) 25 (28.1) 85 (25.9) 218 (32.7) 15 (15.8)
2–5 1225 (41.1) 296 (39.3) 162 (26.0) 272 (64.0) 38 (42.7) 148 (45.1) 282 (42.3) 27 (28.4)
≥6 1010 (33.9) 295 (39.1) 338 (54.3) 36 (8.5) 26 (29.2) 95 (29.0) 167 (25.0) 53 (55.8)
Thrombolysis 256 (7.8) 55 (6.8) 123 (18.0) 7 (1.4) 5 (5.3) 25 (7.2) 36 (5.2) 5 (3.2) 0.027
Antithrombotic 3194 (97.4) 793 (97.8) 652 (95.6) 485 (99.2) 90 (95.7) 346 (99.1) 687 (98.7) 141 (89.8) <0.001
Antiplatelet 2660 (81.1) 737 (90.9) 328 (48.1) 470 (96.1) 65 (69.1) 289 (82.8) 656 (94.3) 115 (73.2) 0.010
Anticoagulant 630 (19.2) 50 (6.2) 397 (58.2) 8 (1.6) 28 (29.8) 111 (31.8) 29 (4.2) 7 (4.5) <0.001
Statin 1625 (49.6) 436 (53.8) 278 (40.8) 219 (44.8) 43 (45.7) 192 (55.0) 430 (61.8) 27 (17.2) <0.001
Length of 
stay, d
8 (6–11) 9 (6–13) 9 (6–14) 6 (5–9) 10 (6–14.25) 8 (6–12) 7 (5–10) 7 (5–15.5) 0.610
<6 794 (24.2) 153 (18.9) 130 (19.1) 194 (39.7) 13 (13.8) 75 (21.5) 181 (26.0) 48 (30.6)
6–9 1283 (39.1) 307 (37.9) 223 (32.7) 203 (41.5) 33 (35.1) 138 (39.5) 325 (46.7) 54 (34.4)
≥10 1201 (36.6) 351 (43.3) 329 (48.2) 92 (18.8) 48 (51.1) 136 (39.0) 190 (27.3) 55 (35.0)
CE indicates cardioembolism; LAA, large artery atherosclerosis; LAC, lacune; NIHSS, National Institute of Health Stroke Scale; SOD, stroke of other determined etiology; 
UI, stroke of undetermined etiology because of incomplete evaluation; UM, stroke of undetermined etiology because of multiple causes; UN, stroke of undetermined 
etiology because of negative evaluation.
Data are expressed as the median (interquartile range) or a N (%).
*P values are compared between UI and other stroke subtypes.
were older, more frequently had diabetes, and less frequently 
were current smokers. The initial stroke severity measured by 
National Institutes of Health Stroke Scale was most severe 
in patients with cardioembolism, followed by an incomplete 
evaluation. Patients with an incomplete evaluation were 
less frequently treated with thrombolysis during admission 
(P=0.027) and with antithrombotic agents or statin at dis-
charge (antithrombotic, P<0.001; antiplatelet, P=0.01; antico-
agulant, P<0.001; and statin, P<0.001) compared with those 
with the other stroke subtypes.
Evaluation of Stroke Etiology
Angiographic evaluations were performed in 92.4% of all 
patients. All of the patients with an incomplete evaluation and 
13.5% of those with cardioembolism did not undergo a cere-
bral angiographic study. Echocardiography was performed in 
50.6% of patients. Continuous ECG monitoring in the stroke 
unit or Holter monitoring was performed in 52.2% of patients. 
Cardiac evaluations were less frequently performed in patients 
with an incomplete evaluation and none underwent heart CT. 
Neurosonologic evaluations were also less frequently per-
formed in patients with an incomplete evaluation. The number 
of patients who were evaluated by at least 1 special cardiac 
evaluation (echocardiography, continuous ECG monitoring, 
or heart CT) was lower in cases of incomplete evaluation than 
in cases of other stroke subtypes (26.8% vs 76.1%; P<0.001; 
Supplemental Table I).
Functional Outcome at 3 Months
The median length of stay was 8 days (IQR, 6–11). The median 
length of stay in patients with an incomplete evaluation was 
not different from that in the other stroke subtypes (7 days and 
IQR 5–15.5 vs 8 days and IQR 6–11; P=0.610). Among the 
3278 patients, data of the modified Rankin Scale at 3 months 
were available in 3088 patients (overall, 94.2%; 95.7% in large 
artery atherosclerosis, 95.6% in cardioembolism, 90.6% in 
lacunar infarction, 93.6% in stroke of other determined eti-
ology, 96.3% in undetermined etiology because of multiple 
causes, 97.1% in negative evaluation, and 74.5% in incomplete 
evaluation). Poor outcome was more frequent in patients with 
an incomplete evaluation than in those with the other stroke 
subtypes (49.6% vs 24.5%; P<0.001). In contrast, patients 
with a negative evaluation were more likely to be independent 
at 3 months (79.7% vs 73.1%; P<0.001). In the multivariate 
analysis, age, initial stroke severity, discharge medications, and 
length of stay were independent predictors of poor outcome at 
3 months. Among the stroke subtypes, the odds ratio for poor 
outcome at 3 months was highest in patients with an incom-
plete evaluation (odds ratio, 3.49; 95% CI, 1.81–6.74; Table 2).
Cumulative Death Rates
During the  follow- up period, 781 patients (23.8%) died. 
Within 30 days, 3.8% of patients died and the overall cumula-
tive death rates were 10.5% within 1 year and 18.4% within 
3 years. Among the stroke subtypes, the overall cumula-
tive death rates were highest in patients with an incom-
plete evaluation (12.7% within 30 days, 25.5% within 1 
year, and 35.7% within 3 years), followed by patients with 
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were older, more frequently had diabetes, and less frequently 
were current smokers. The initial stroke severity measured by 
National Institutes of Health Stroke Scale was most severe 
in patients with cardioembolism, followed by an incomplete 
evaluation. Patients with an incomplete evaluation were 
less frequently treated with thrombolysis during admission 
(P=0.027) and with antithrombotic agents or statin at dis-
charge (antithrombotic, P<0.001; antiplatelet, P=0.01; antico-
agulant, P<0.001; and statin, P<0.001) compared with those 
with the other stroke subtypes.
Evaluation of Stroke Etiology
Angiographic evaluations were performed in 92.4% of all 
patients. All of the patients with an incomplete evaluation and 
13.5% of those with cardioembolism did not undergo a cere-
bral angiographic study. Echocardiography was performed in 
50.6% of patients. Continuous ECG monitoring in the stroke 
unit or Holter monitoring was performed in 52.2% of patients. 
Cardiac evaluations were less frequently performed in patients 
with an incomplete evaluation and none underwent heart CT. 
Neurosonologic evaluations were also less frequently per-
formed in patients with an incomplete evaluation. The number 
of patients who were evaluated by at least 1 special cardiac 
evaluation (echocardiography, continuous ECG monitoring, 
or heart CT) was lower in cases of incomplete evaluation than 
in cases of other stroke subtypes (26.8% vs 76.1%; P<0.001; 
Supplemental Table I).
Functional Outcome at 3 Months
The median length of stay was 8 days (IQR, 6–11). The median 
length of stay in patients with an incomplete evaluation was 
not different from that in the other stroke subtypes (7 days and 
IQR 5–15.5 vs 8 days and IQR 6–11; P=0.610). Among the 
3278 patients, data of the modified Rankin Scale at 3 months 
were available in 3088 patients (overall, 94.2%; 95.7% in large 
artery atherosclerosis, 95.6% in cardioembolism, 90.6% in 
lacunar infarction, 93.6% in stroke of other determined eti-
ology, 96.3% in undetermined etiology because of multiple 
causes, 97.1% in negative evaluation, and 74.5% in incomplete 
evaluation). Poor outcome was more frequent in patients with 
an incomplete evaluation than in those with the other stroke 
subtypes (49.6% vs 24.5%; P<0.001). In contrast, patients 
with a negative evaluation were more likely to be independent 
at 3 months (79.7% vs 73.1%; P<0.001). In the multivariate 
analysis, age, initial stroke severity, discharge medications, and 
length of stay were independent predictors of poor outcome at 
3 months. Among the stroke subtypes, the odds ratio for poor 
outcome at 3 months was highest in patients with an incom-
plete evaluation (odds ratio, 3.49; 95% CI, 1.81–6.74; Table 2).
Cumulative Death Rates
During the  follow- up period, 781 patients (23.8%) died. 
Within 30 days, 3.8% of patients died and the overall cumula-
tive death rates were 10.5% within 1 year and 18.4% within 
3 years. Among the stroke subtypes, the overall cumula-
tive death rates were highest in patients with an incom-
plete evaluation (12.7% within 30 days, 25.5% within 1 
year, and 35.7% within 3 years), followed by patients with 
cardioembolism (10.1% within 30 days, 20% within 1 year, 
and 30.1% within 3 years). In total, 512 patients (15.6%) died 
because of cardiovascular causes (stroke or ischemic heart 
disease). Cumulative cardiovascular death rates were 3.3% 
within 30 days, 7.8% within 1 year, and 12.7% within 3 years. 
Cumulative cardiovascular death rates were highest in patients 
with an incomplete evaluation, followed by those with car-
dioembolism. Among the cases of cardiovascular death, 403 
patients (78.7%) died of stroke, whereas 109 (21.3%) patients 
died of ischemic heart disease. Cumulative rates for fatal 
stroke within 30 days, 1 year, and 3 years were highest in 
patients with an incomplete evaluation, whereas cumulative 
rates for fatal ischemic heart disease within 30 days, 1 year, 
and 3 years were highest in patients with cardioembolism 
(Figure 1 and Supplemental Figure II). The  Kaplan- Meier sur-
vival analysis revealed that more patients with an incomplete 
evaluation died during  long- term  follow- up compared with 
other stroke subtypes (P<0.001; Figure 2A). After exclud-
ing early deaths within 30 days, patients with an incomplete 
evaluation showed still higher  long- term mortality (P<0.001; 
Supplemental Figure III).
Univariate and Multivariate Analyses of  
Long- Term Mortality
Univariate Cox regression analyses revealed that older age, being 
female, history of hypertension, atrial fibrillation, not being 
a current smoker, and initial stroke severity were associated 
with  long- term mortality. Multivariate Cox regression analyses 
revealed that older age, being female, history of diabetes, and 
initial stroke severity were associated with  long- term mortality. 
In comparison with lacunar infarction, the risk of  long- term 
death was highest in patients with cardioembolism, followed by 
those with an incomplete evaluation. Patients with an incom-
plete evaluation showed a 2.53-fold higher death rate compared 
with those with lacunar infarction. In contrast, the mortality of 
patients with a negative evaluation was second lowest after lacu-
nar infarction (Table 3 and Figure 2B). After bootstrapping for 
internal validation, the concordance index, indicating the prob-
ability that the Cox regression model would predict the correct 
order of survival times of randomly drawn patients was calcu-
lated. The concordance index value of 1.0 is equivalent to a per-
fect prediction, whereas a value of 0.5 corresponds to a coin flip. 
The concordance index of internal validation models was 0.78 
(95% CI, 0.76–0.80), which was very similar to that of current 
multivariate model (0.78; 95% CI, 0.76–0.81).
Comparison to the Mortality in the  
General Population
Overall patients with stroke showed significantly higher mor-
tality compared with the general population.  Sex- adjusted 
and  age- adjusted SMR was 13.87 (95% CI, 11.61–16.46) 
for 30 days, 3.39 (95% CI, 3.04–5.62) for 1 year, and 2.26 
(95% CI, 2.08–2.45) for 3 years. Among the stroke subtype, 
patients with stroke of undetermined etiology because of 
incomplete evaluation showed the highest SMR (49.70 for 
30 days, 10.23 for 1 year, and 5.40 for 3 years). Meanwhile, 
patients with stroke of undetermined etiology because of 
multiple causes or because of negative evaluation showed 
 at CONS KESLI on September 1, 2014http://stroke.ahajournals.org/Downloaded from 
2952  Stroke  November 2012
moderately or slightly increased mortality; SMR of multiple 
causes was 6.54 for 30 days, 2.33 for 1 year, and 1.92 for 3 
years; SMR of negative evaluation was 4.95 for 30 days, 1.80 
for 1 year, and 1.36 for 3 years (Table 4).
Discussion
We investigated the  long- term mortality and functional out-
come at 3 months of stroke patients with undetermined etiolo-
gies and showed that the  long- term mortality and functional 
outcome of patients with undetermined etiologies were het-
erogeneous according to the stroke subtype. Our attention was 
first drawn to the very high  short- term and  long- term mortality 
rates as well as poor functional outcome in patients with an 
incomplete evaluation.
There are several possible explanations for high mortal-
ity in patients with an incomplete evaluation. Patients with 
an incomplete evaluation might be prone to a higher risk of 
recurrent stroke, including fatal stroke. Actually, in our study, 
fatal stroke developed more frequently in the patients with an 
incomplete evaluation. All patients with an incomplete evalu-
ation did not undergo an angiographic evaluation; therefore, 
the presence of significant carotid stenosis that might require 
stent/carotid endarterectomy could be missed. In addition, 
the presence of intracranial atherosclerosis is associated with 
higher risks of  long- term mortality and stroke recurrence.24 
Lack of those evaluations and treatments in some patients 
with an incomplete evaluation could result in an increased risk 
of stroke recurrence and death.
Table 2. Univariate and Multivariate Analysis for Poor Outcome at 3 Months (Modified Rankin 
Scale Score 3–6)
Univariate Multivariate*
OR (95% CI) P  Value OR (95% CI) P  Value
Age
<60 1 1
60–79 1.82 (1.5–2.22) <0.001 1.87 (1.46–2.40) <0.001
≥80 4.73 (3.51–6.37) <0.001 3.20 (2.19–4.70) <0.001
Female 1.53 (1.3–1.8) <0.001 1.22 (0.95–1.57) 0.119
Hypertension 1.09 (0.91–1.3) 0.358
Diabetes 1.11 (0.93–1.32) 0.234
Smoking 0.73 (0.62–0.86) <0.001 0.98 (0.76–1.26) 0.870
Atrial fibrillation 3.05 (2.5–3.71) <0.001
Hyperlipidemia 1.13 (0.88–1.45) 0.356
Initial NIHSS score
0–2 1 1
3–6 3.44 (2.27–5.21) <0.001 3.27 (2.14–5.00) <0.001
≥7 31.17 (20.94–46.38) <0.001 22.20 (14.64–33.68) <0.001
Discharge medication
Antithrombotic 0.11 (0.06–0.18) <0.001 0.15 (0.08–0.30) <0.001
Statin 1.15 (0.98–1.36) 0.084 2.24 (1.80–2.80) <0.001
Length of stay (d)
<6 1 1
6–9 0.95 (0.75–1.21) 0.675 0.97 (0.71–1.33) 0.869
≥10 3.56 (2.85–4.45) <0.001 2.39 (1.77–3.21) <0.001
Stroke subtypes
LAC 1 1
CE 5.72 (3.97–8.25) <0.001 1.75 (1.11–2.75) 0.015
LAA 4.1 (2.85–5.9) <0.001 1.74 (1.12–2.70) 0.014
SOD 2.85 (1.56–5.22) 0.001 2.12 (1.02–4.39) 0.044
UM 3.34 (2.21–5.05) <0.001 1.83 (1.11–3.02) 0.018
UN 2.63 (1.8–3.84) <0.001 1.79 (1.14–2.83) 0.012
UI 10.18 (6.24–16.61) <0.001 3.49 (1.81–6.74) <0.001
CE indicates cardioembolism; CI, confidence interval; LAA, large artery atherosclerosis; LAC, lacune; NIHSS, National 
Institute of Health Stroke Scale; OR, odds ratio; SOD, stroke of other determined etiology; UI, stroke of undetermined 
etiology because of incomplete evaluation; UM, stroke of undetermined etiology because of multiple causes; UN, stroke 
of undetermined etiology because of negative evaluation.
*Variables (age, sex, smoking, initial NIHSS scores, medications at discharge, length of stay, and stroke subtypes), 
which showed P<0.1 in the univariate analysis, were included in the multivariate analysis.
Several studies indicated that higher utilization of tests for 
stroke evaluation can improve outcomes in acute ischemic 
stroke patients.25,26 In our study, only 26.8% of patients with 
an incomplete evaluation underwent at least 1 special cardiac 
assessment, whereas 76.1% of the other stroke subtypes under-
went at least 1 special cardiac assessment. Detection of cardio-
embolic sources depends on the depth of cardiac evaluation.13 
Asymptomatic coronary artery atherosclerosis was present in 
≈60% to 70% of stroke patients.16,27 Lack of evaluation for the 
potential cardiac sources of embolism or failure to detect seri-
ous underlying heart diseases such as coronary artery disease 
might have increased the risk of  long- term death.
Another explanation for the higher mortality in patients 
with incomplete evaluation may be related to the initially 
severe neurological deficits in these patients. The initial 
severity of a stroke is one of the major predictors of poor 
outcome and mortality after the index stroke.1,28,29 Severe 
neurological deficits in patients with an incomplete evalua-
tion might lead to poor  long- term outcomes. In some patients, 
the neurological conditions might have been too severe 
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Several studies indicated that higher utilization of tests for 
stroke evaluation can improve outcomes in acute ischemic 
stroke patients.25,26 In our study, only 26.8% of patients with 
an incomplete evaluation underwent at least 1 special cardiac 
assessment, whereas 76.1% of the other stroke subtypes under-
went at least 1 special cardiac assessment. Detection of cardio-
embolic sources depends on the depth of cardiac evaluation.13 
Asymptomatic coronary artery atherosclerosis was present in 
≈60% to 70% of stroke patients.16,27 Lack of evaluation for the 
potential cardiac sources of embolism or failure to detect seri-
ous underlying heart diseases such as coronary artery disease 
might have increased the risk of  long- term death.
Another explanation for the higher mortality in patients 
with incomplete evaluation may be related to the initially 
severe neurological deficits in these patients. The initial 
severity of a stroke is one of the major predictors of poor 
outcome and mortality after the index stroke.1,28,29 Severe 
neurological deficits in patients with an incomplete evalua-
tion might lead to poor  long- term outcomes. In some patients, 
the neurological conditions might have been too severe 
to proceed with an etiologic  work- up, which resulted in an 
incomplete evaluation.
Patients with an incomplete evaluation were less frequently 
treated with thrombolysis during admission and with antithrom-
botic agents or statin at discharge compared with those with the 
other stroke subtypes. Besides appropriate drug treatment and 
intervention or surgery, lifestyle changes and aggressive risk fac-
tor control are essential for preventing cardiovascular events.30 
Although our study did not investigate these factors, it can be 
assumed that patients with an incomplete evaluation might be 
less compliant to preventive treatments and might be reluctant 
to lifestyle changes when considering the fact that many of the 
patients with an incomplete evaluation were those who refused 
or were reluctant to undergo stroke evaluation during admission.
In contrast to patients with an incomplete evaluation, the 
 long- term outcomes of patients with negative evaluation were 
favorable. Patients with a negative evaluation did not have 
significant large artery atherosclerosis or obvious potential 
cardiac sources of embolism, which are 2 major etiologies 
associated with poor outcome. The risk of recurrent stroke in 
Figure 1. Cumulative death rates according to the stroke subtypes. Overall cumulative death rates (A) and cumulative rates for fatal 
stroke (B) within 30 days, 1 year, and 3 years were highest in patients with an incomplete evaluation. LAC, lacune; CE, cardioembolism; 
LAA, large artery atherosclerosis; SOD, stroke of other determined etiology; UM, stroke of undetermined etiology because of multiple 
causes; UN, stroke of undetermined etiology because of negative evaluation; UI, stroke of undetermined etiology because of incomplete 
evaluation; mRS, modified Rankin Scale.
Figure 2.  Kaplan–Meier survival curve and Cox regression survival curve according to the stroke subtypes. Univariate  Kaplan– Meier  
survival analysis revealed that more patients with an incomplete evaluation (red) died during  follow- up compared with other stroke subtypes 
(P<0.001) (A). Multivariate Cox regression curve shows that the risk of  long- term death was second highest in patients with an  
incomplete evaluation (red) after cardioembolism (green) after adjustment of age, sex, hypertension, diabetes, smoking, initial stroke 
severity, discharge medications, and length of hospital stay (B). LAC, lacune; CE, cardioembolism; LAA, large artery atherosclerosis; 
SOD, stroke of other determined etiology; UM, stroke of undetermined etiology because of multiple causes; UN, stroke of undetermined 
etiology because of negative evaluation; UI, stroke of undetermined etiology because of incomplete evaluation.
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these patients might be lower than that in patients with large 
artery atherosclerosis or with  high- risk cardiac sources of 
embolism. Moreover, the initial stroke severity in patients 
with a negative evaluation was mild. These factors might be 
responsible for the low risk of  long- term death in patients with 
a negative evaluation.
To estimate the risk of  long- term mortality accord-
ing to stroke etiologies compared with a  sex- matched and 
 age- matched general Korean population, we calculated the 
SMR. Poor outcomes of patients with an incomplete evalua-
tion were consistent even after adjustment for sex and age. The 
SMR within 30 days was almost 50-times higher in patients 
with an incomplete evaluation.
This study has several limitations. First, although we 
assumed that higher mortality in patients with an incomplete 
evaluation was partly attributed to an increased risk of stroke 
recurrence, we only could obtain the data for fatal strokes. 
Therefore, based on our data set, we could not determine 
the actual frequency of all stroke recurrences, including 
fatal and nonfatal strokes. Second, information on treatment 
compliance in patients with an incomplete evaluation might 
have provided a basis for their higher mortality. However, 
we could not obtain data on treatment compliance for each 
patient. Third, the definition of an “incomplete evaluation” 
could differ among studies or physicians. Although we 
regarded brain CT/magnetic resonance imaging, cerebral 
angiographic studies, and ECG as essential diagnostic stud-
ies, other investigators may consider other additional studies 
including echocardiographic studies to be essential in some 
patients. Individualization of definition for “incomplete 
Table 3. Cox Regression Analysis of  Long- Term Mortality
Univariate Multivariate*
HR (95% CI) P  Value HR (95% CI) P  Value
Age (y)
<60 1 1
60–79 2.90 (2.37–3.56) <0.001 2.78 (2.19–3.52) <0.001
≥80 7.66 (5.97–9.82) <0.001 6.10 (4.58–8.13) <0.001
Female) 1.19 (1.03–1.37) 0.016 0.84 (0.70–1.01) 0.064
Hypertension 1.18 (1.01–1.37) 0.042 1.07 (0.90–1.28) 0.423
Diabetes 1.15 (1.00–1.34) 0.059 1.15 (0.98–1.36) 0.096
Atrial fibrillation 3.46 (2.97–4.03) <0.001
Smoking 0.75 (0.64–0.87) <0.001 0.92 (0.76–1.10) 0.288
Hyperlipidemia 0.91 (0.73–1.13) 0.403
Initial NIHSS score
0–2 1 1
3–6 1.67 (1.31–2.12) <0.001 1.63 (1.28–2.08) <0.001
≥7 4.49 (3.66–5.49) <0.001 3.21 (2.57–4.02) <0.001
Discharge medication
Antithrombotic 0.17 (0.13–0.22) <0.001 0.23 (0.17–0.31) <0.001
Statin 0.67 (0.57–0.79) <0.001 0.81 (0.68–0.97) 0.019
Length of stay (d)
<6 1 1
6–9 0.70 (0.58–0.86) 0.001 0.64 (0.51–0.79) <0.001
≥10 1.29 (1.07–1.54) 0.007 0.81 (0.65–1.00) 0.052
Stroke subtypes
LAC 1 1
CE 4.45 (3.31–5.98) <0.001 2.84 (2.01–4.02) <0.001
LAA 2.80 (2.07–3.78) <0.001 2.03 (1.44–2.86) <0.001
SOD 1.45 (0.79–2.65) 0.232 1.95 (1.01–3.76) 0.045
UM 3.11 (2.23–4.35) <0.001 2.48 (1.70–3.61) <0.001
UN 1.65 (1.19–2.30) 0.003 1.67 (1.16–2.41) 0.006
UI 4.80 (3.38–6.80) <0.001 2.53 (1.63–3.91) <0.001
CE indicates cardioembolism; CI, confidence interval; HR, hazard ratio; LAA, large artery atherosclerosis; LAC, 
lacune; NIHSS, National Institute of Health Stroke Scale; SOD, stroke of other determined etiology; UI, stroke of 
undetermined etiology because of incomplete evaluation; UM, stroke of undetermined etiology because of multiple 
causes; UN, stroke of undetermined etiology because of negative evaluation.
*Variables (age, sex, hypertension, diabetes, smoking, initial NIHSS scores, medications at discharge, length of 
stay, and stroke subtypes), which showed P<0.1 in the univariate analysis, were included in the multivariate analysis.
 at CONS KESLI on September 1, 2014http://stroke.ahajournals.org/Downloaded from 
Nam et al  Unknown Cause of Stroke and Mortality  2955
evaluation” at the physician’s own discretion may be sub-
jected to variability of the subtype classification according to 
the rating physicians even in the similar cases. Therefore, we 
used a rather simple and uniform definition of essential stud-
ies to determine “incomplete evaluation.” Fourth, although 
odds ratio for poor functional outcome at 3 months was high-
est in patients with an incomplete evaluation among stroke 
subtypes after adjusting the factors that were significant in 
univariate analysis, there is a possibility of residual confound-
ing. Fifth, the indirect standardization method controlled sex 
and age differences between the stroke patients and the gen-
eral population, but could not control other factors affecting 
the mortality. Moreover, the SMR of 2 different stroke sub-
types could not be directly compared, even though they were 
calculated in comparison to the same general population. 
Thus, the SMR should be carefully interpreted as an indica-
tor assessing whether the mortality of patients with a certain 
stroke subtype is higher or lower than the mortality in a gen-
eral population of same sex and age.
Conclusions
This study demonstrated that  long- term mortality is quite dif-
ferent among stroke patients with undetermined etiology. The 
mortality was very high in patients for whom the stroke etiology 
was incompletely evaluated during hospitalization. However, 
the mortality was low in patients for whom the stroke etiology 
was not determined despite extensive  work- up. Taken together, 
our findings suggest the importance of initial evaluation for 
defining the stroke subtype and determining the prognosis.
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Table 4. Population- Adjusted Standardized Mortality Ratio and Rate*
Standardized  
Mortality Ratio*
Standardized Mortality Rate, 
Per 100000  
Person-Years
N of 
Patients
Observed N 
of Deaths
Expected N 
of Deaths Estimate 95% CI Estimate 95% CI
Within 30 d
All 3278 126 9.08 13.87 11.61–16.46 445.6 367.2–535.3
LAC 489 0 1.15 N/A N/A N/A N/A
CE 682 70 1.66 42.06 33.12–52.96 1308.9 1023.9–1656.2
LAA 811 18 2.73 6.59 4.03–10.22 232.6 126.1–383.6
SOD 94 1 0.09 10.76 0.54–53.03 118.2 −5.6 to 630.3
UM 349 8 1.22 6.54 3.05–12.45 239.8 88.5–495.3
UN 696 9 1.82 4.95 2.41–9.07 126.7 45.3–259.1
UI 157 20 0.40 49.70 31.40–75.85 1674.4 1045.1–2573.3
Within 1 y
All 3278 342 100.9 3.39 3.04–5.62 81.2 69.5–156.9
LAC 489 7 13.77 0.51 0.22–1.01 −14.1 −22.4 to 0.2
CE 682 136 17.27 7.88 6.63–9.29 211.9 173.6–255.3
LAA 811 83 30.20 2.75 2.20–3.39 71.1 48.9–97.2
SOD 94 6 0.93 6.43 2.61–13.42 57.3 17.0–131.0
UM 349 32 13.71 2.33 1.62–3.26 57.2 26.7–96.6
UN 696 38 21.11 1.80 1.29–2.45 25.8 9.4–46.7
UI 157 40 3.91 10.23 7.41–13.79 290.9 201.9–403.2
Within 3 y
All 3278 547 242.17 2.26 2.08–2.45 41.0 35.0–47.3
LAC 489 25 36.80 0.68 0.45–0.99 −9.2 −15.8 to −0.3
CE 682 190 40.07 4.74 4.10–5.45 109.3 90.6–130.1
LAA 811 139 70.90 1.96 1.65–2.31 37.0 25.2–50.3
SOD 94 9 1.89 4.76 2.32–8.74 32.0 11.3–65.9
UM 349 59 30.74 1.92 1.47–2.46 36.9 19.0–58.5
UN 696 70 51.59 1.36 1.07–1.70 11.3 2.1–22.4
UI 157 55 10.19 5.40 4.11–6.97 136.6 96.5–185.6
CE indicates cardioembolism; CI, confidence interval; LAA, large artery atherosclerosis; LAC, lacune; NIHSS, National Institute of 
Health Stroke Scale; SOD, stroke of other determined etiology; UI, stroke of undetermined etiology because of incomplete evaluation; 
UM, stroke of undetermined etiology because of multiple causes; UN, stroke of undetermined etiology because of negative evaluation.
*The standardized mortality ratio was indirectly adjusted for sex and age, compared with the mortality of the Korean population 
in 2003.
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SUPPLEMENTAL MATERIAL 
 
 
Supplemental Figure 1. The catchment area and population nearby the study hospital. 
 
The study hospital is a 2000-bed general hospital located in the western part of Seoul, the capital 
city of South Korea. About 80% of stroke patients who admit to the study hospital are from 
Seoul and Gyeonggi province where hold about 20 million inhabitants. 
 
 
 
 
The names of the provinces, number of the population, and the percent of stroke patients who 
admit to the study hospital are shown in the box. 
Supplemental Figure 2. Cumulative death rates according to the stroke subtypes. 
 
The cumulative cardiovascular death rates (A) and cumulative rates for fatal ischemic heart 
disease (B) within 30 days, 1 year, and 3 years are shown. The cumulative cardiovascular death 
rates were highest in patients with an incomplete evaluation. Cumulative rates for fatal ischemic 
heart disease were highest in patients with cardioembolism. 
 
 
 
LAC: lacune, CE: cardioembolism, LAA: large artery atherosclerosis, SOD: stroke of other 
determined etiology, UM: stroke of undetermined etiology due to multiple causes, UN: stroke of 
undetermined etiology due to negative evaluation, UI: stroke of undetermined etiology due to 
incomplete evaluation. 
Supplemental Figure 3. Kaplan-Meier Survival curves of the patients who survived for 
more than 30 days according to the stroke subtypes. 
 
Among the patients who survived for more than 30 days, those with an incomplete evaluation 
still showed the highest long-term mortality after adjustment of age, sex, hypertension, diabetes, 
smoking, initial stroke severity, discharge medications, and length of hospital stay. 
 
 
 
LAC: lacune, CE: cardioembolism, LAA: large artery atherosclerosis, SOD: stroke of other 
determined etiology, UM: stroke of undetermined etiology due to multiple causes, UN: stroke of 
undetermined etiology due to negative evaluation, UI: stroke of undetermined etiology due to 
incomplete evaluation. 
Supplemental Table 1. Etiologic evaluations according to stroke subtypes 
 
 
Total LAA CE LAC SOD UM UN UI P* 
 
3278 (100) 811 (25) 682 (20) 489 (15) 94 (3) 349 (11) 696 (21) 157 (5)  
Angiographic evaluations 3029 (92.4) 811 (100) 590 (86.5) 489 (100) 94 (100) 349 (100) 696 (100) 0 (0) <0.001 
CTA 442 (13.5) 99 (12.2) 126 (18.5) 49 (10.0) 6 (6.4) 50 (14.3) 112 (16.1) 0 (0) <0.001 
MRA 2325 (70.9) 608 (75.0) 425 (62.3) 390 (79.8) 63 (67.0) 264 (75.6) 575 (82.6) 0 (0) <0.001 
DSA 1153 (35.2) 392 (48.3) 236 (34.6) 109 (22.3) 64 (68.1) 132 (37.8) 220 (31.6) 0 (0) <0.001 
Neurosonographic 
evaluations 
1094 (33.4) 307 (37.9) 201 (29.5) 129 (26.4) 35 (37.2) 132 (37.8) 279 (40.1) 11 (7.0) <0.001 
Carotid Doppler 816 (24.9) 207 (25.5) 153 (22.4) 96 (19.6) 25 (26.6) 98 (28.1) 234 (33.6) 3 (1.9) <0.001 
TCD 1076 (32.8) 126 (25.8) 197 (28.9) 126 (25.8) 34 (36.2) 127 (36.4) 277 (39.8) 11 (7.0) <0.001 
Echocardiography 1660 (50.6) 351 (39.1) 447 (65.5) 191 (39.1) 50 (53.2) 243 (69.6) 358 (51.4) 20 (12.7) <0.001 
TEE 1432 (43.7) 319 (39.3) 353 (51.8) 181 (37.0) 41 (43.6) 202 (57.9) 317 (45.5) 19 (12.1) <0.001 
TTE 361 (11.0) 45 (5.5) 166 (24.3) 45 (5.5) 10 (10.6) 64 (18.3) 57 (8.2) 1 (0.6) <0.001 
Continuous ECG monitoring 1712 (52.2) 414 (51) 392 (57.5) 207 (42.3) 48 (51.1) 191 (54.7) 434 (62.4) 26 (16.6) <0.001 
Heart CT 200 (6.1) 55 (6.8) 35 (5.1) 21 (4.3) 5 (5.3) 29 (8.3) 55 (7.9) 0 (0) 0.001 
          
At least one special cardiac 
evaluation performed† 
2417 (73.7) 570 (70.3) 581 (85.2) 300 (61.3) 72 (76.6) 299 (85.7) 553 (79.5) 42 (26.8) <0.001 
 
* P-values are compared between UI and other stroke subtypes.  
†Special cardiac evaluation includes echocardiography, continuous ECG monitoring, and heart CT. 
 
Data are expressed as a number (%). LAA: large artery atherosclerosis, LAC: lacune, CE: cardioembolism, SOD: stroke of other determined 
etiology, UM: stroke of undetermined etiology due to multiple causes, UN: stroke of undetermined etiology due to negative evaluation, UI: 
stroke of undetermined etiology due to incomplete evaluation, CTA: CT angiography, MRA: MR angiography, DSA: digital subtraction 
angiography, TEE: transesophageal echocardiography, TTE: transthoracic echocardiography, ECG: electrocardiography, TCD: transcranial 
Doppler.  
